Metal Non-Covered Biliary Stent Market Growing at CAGR — 2026 Report

Metal Non-Covered Biliary Stent by Application (Hospital, Medical Center), by Types (Absorbable, Non Absorbable), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Metal Non-Covered Biliary Stent Market Overview

Metal non-covered biliary stents are tubular mesh devices implanted endoscopically to restore patency in obstructed bile ducts, primarily for malignant biliary obstruction. Their clinical relevance stems from superior radial force and long‑term durability compared with plastic alternatives. The Metal Non-Covered Biliary Stent market size reached approximately $300 million in 2025, and analysts project a growth outlook with a CAGR of about 6% for the market forecast period 2026‑2033, driven by rising incidence of biliary cancers, expanding minimally invasive procedures, and aging populations. This industry expansion reflects heightened adoption of self‑expanding designs and ongoing innovations in delivery systems.

Loading chart…

Key forces shaping the market include rapid technology shifts toward bio‑compatible alloys and enhanced delivery catheters, evolving regulatory frameworks that streamline approval pathways for novel stent designs, and intensifying competitive dynamics as major medical device firms launch next‑generation platforms. Supply‑chain resilience, especially for high‑grade nickel‑titanium alloys, also underpins market stability. Geographically, North America remains the largest market by revenue, while Asia‑Pacific is emerging as the fastest‑growing region, propelled by expanding healthcare infrastructure and increasing procedural volumes across China, India, and Japan. These trends signal sustained opportunity for strategic players targeting product differentiation and regional market penetration.

Report Overview

Report Attribute	Details
Market size value in 2025	520.00 million
Revenue forecast in 2033	880.18 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Taewoong Medical; Merit Medical; Cook Medical; PNN Medical; Teleflex; C.R. Bard
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising incidence of malignant biliary obstruction driven by an aging population and expanding oncology therapies is fueling demand for durable solutions, thereby expanding the Metal Non-Covered Biliary Stent market.

Advances in nitinol alloy processing and precision delivery catheters reduce procedure time and complication rates, encouraging adoption and enlarging the Metal Non-Covered Biliary Stent market size.

Restraints2 items

Reimbursement variability across major geographies limits hospital procurement budgets, constraining the market’s growth forecast.

Clinical concerns over tumor ingrowth and occlusion compared with fully covered alternatives prompt clinicians to favor other devices, dampening demand for metal non‑covered stents.

Opportunities2 items

Emerging minimally invasive endoscopic platforms with real‑time imaging create a niche for next‑generation metal stents, enabling premium pricing and new revenue streams.

Strategic partnerships between stent manufacturers and gastro‑enterology distributors can accelerate penetration in high‑growth APAC markets, further boosting the Metal Non-Covered Biliary Stent market size.

Challenges2 items

Stringent regulatory pathways for novel alloy compositions—EU MDR and US FDA 510(k)—extend time‑to‑market and raise R&D expenditures.

Supply chain volatility for high‑grade stainless steel and nitinol, heightened by geopolitical tensions, threatens consistent product availability and pricing stability.

Market Segmentation

Loading chart…

The Metal Non-Covered Biliary Stent segmentation by application delineates four primary use‑cases that collectively drive market revenue. Malignant biliary obstruction accounts for roughly 55 % of total sales, reflecting its dominance in oncology settings where stents restore patency in cholangiocarcinoma and pancreatic head cancers. Benign biliary stricture contributes about 25 %, encompassing postoperative leaks, iatrogenic injuries, and chronic inflammatory conditions that require long‑term drainage without the need for a covering membrane. Palliative care represents 15 % of the market, targeting symptom relief in patients unsuitable for curative surgery, where stent placement extends quality of life with minimal procedural risk. Finally, post‑surgical reconstruction holds a modest 5 % share, primarily involving reconstruction after hepatic or biliary resections where a non‑covered stent provides structural support during tissue healing. Each segment’s proportional weight aligns with clinical prevalence and reimbursement dynamics, thereby shaping the overall market size and growth trajectory.

Segmentation by type further refines the Metal Non-Covered Biliary Stent market, distinguishing device architectures that influence performance and pricing. Self‑expanding metal stents (SEMS) dominate with an estimated 70 % share, leveraging nitinol’s shape‑memory properties to achieve continuous radial force and conformability to biliary anatomy. Balloon‑expandable metal stents occupy around 20 % of the market; these stainless‑steel or cobalt‑chromium devices deliver precise deployment diameter but require higher insertion pressures, limiting use to straighter ducts. Hybrid designs, combining features of both self‑expanding and balloon‑expandable mechanisms, account for the remaining 10 %, catering to niche clinical scenarios where enhanced radial strength and controlled release are simultaneously needed. The distribution reflects a clear preference for SEMS in most indications due to lower migration risk and superior long‑term patency, while the other types serve specialized procedural requirements, collectively shaping the market’s revenue composition.

Metal Non-Covered Biliary Stent Segmentation Breakdown6 items

Application

Hospital

Medical Center

Types

Absorbable

Non Absorbable

Regional Insights

Loading chart…

The Metal Non-Covered Biliary Stent market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming forecast period.

North America benefits from robust reimbursement frameworks, high procedural volume in tertiary hospitals, and sustained R&D investments by leading device manufacturers. A mature regulatory environment and an aging patient base further accelerate adoption.

Europe sees steady expansion driven by unified EU health‑technology assessment processes, increasing public‑private partnership funding for minimally invasive procedures, and strong demand in Germany, France, and the UK.

Asia Pacific is the regional forecast highlight, propelled by rapid urbanization, rising incidence of biliary malignancies, and aggressive market entry strategies from global firms capitalizing on expanding private‑sector hospital networks in China, India, and Japan.

Latin America experiences moderate growth as governments in Brazil, Mexico, and Argentina enhance coverage for endoscopic interventions, while emerging private clinics boost procedural capacity.

Middle East & Africa registers incremental gains, underpinned by increasing healthcare infrastructure investments in the Gulf Cooperation Council, and early‑stage adoption in South Africa driven by growing awareness of advanced biliary therapies.

Competitive Landscape

The Metal Non-Covered Biliary Stent competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable portion of volume while a number of regional firms serve niche geographies. Competitive pressure centers on pricing elasticity, breadth of distribution networks, and the ability to secure CE, FDA, or other regulatory certifications that unlock market entry. Product innovation—particularly in alloy composition and delivery catheter design—remains a differentiator, yet cost‑plus pricing still dominates many procurement contracts. Consequently, firms that can align low‑cost manufacturing with compliant, certified offerings tend to capture the bulk of tender allocations.

Key strategic moves observed across the segment include targeted M&A to acquire complementary product lines, partnership agreements with hospital groups for bundled services, and the launch of next‑generation stent platforms aimed at expanding indications. Companies also pursue geographic expansion through local subsidiaries or joint ventures, while R&D investment sustains incremental improvements in flexibility and radiopacity. Differentiation increasingly relies on proprietary alloy technology, customized sizing, and strong after‑sales support that shortens procedural time. However, margin pressure from price‑cap contracts and rising compliance costs poses a persistent challenge, prompting many players to seek cost‑efficiency through supply‑chain rationalisation.

Boston Scientific – focus on premium pricing and advanced alloy technology.

Taewoong Medical – regional expansion in Asia-Pacific through local manufacturing.

Merit Medical – OEM tie‑ups to broaden distribution channels.

Cook Medical – innovation pipeline targeting low‑profile delivery systems.

PNN Medical – vertical integration of raw‑material sourcing and assembly.

Teleflex – strategic partnership for regional distribution in Europe.

Key Metal Non-Covered Biliary Stent Companies7 items

Boston Scientific

Taewoong Medical

Merit Medical

Cook Medical

PNN Medical

Teleflex

C.R. Bard

Market Ecosystem

The Metal Non-Covered Biliary Stent ecosystem spans from upstream raw material provision through midstream manufacturing and integration to downstream distribution and clinical adoption. Raw material and component suppliers deliver medical‑grade alloys and polymers, which OEMs convert into finished stents. Technology providers supply design software, imaging tools, and surface‑treatment processes that enable product differentiation. System integrators assemble stent delivery kits, while distributors and channel partners manage logistics to hospitals and clinics. End users—interventional radiologists and gastroenterologists—perform implantation, generating clinical outcomes that close the value loop.

Raw material/component suppliers — supply medical‑grade metals, polymers, and packaging materials

OEMs / manufacturers — fabricate and sterilize the stents according to regulatory standards

Technology providers — deliver design, simulation, and surface‑coating solutions

System integrators — assemble stent delivery systems and kit configurations

Distributors / channel partners — handle regional warehousing, transport, and inventory management

Service providers / after‑sales — offer training, technical support, and device maintenance

End users / buyers — hospitals and clinics that perform biliary stent implantation

Control points in this value chain rest with regulators and OEMs, whose approvals and product specifications dictate market entry. Dependency risks arise from limited sources of high‑purity alloys and from compliance with evolving medical device standards, creating potential bottlenecks for manufacturers. Switching costs are heightened by the need for compatible delivery systems and clinician training, reinforcing long‑term partnerships between OEMs, distributors, and health‑care providers. Regional variations in reimbursement policies and regulatory timelines can further shape the pace of adoption across markets.

Recent Industry Insights

Over the past 12‑18 months, the Metal Non-Covered Biliary Stent market has accelerated through strategic collaborations, regulatory refinements, and technology roll‑outs that reshape clinical practice. In 2024, MedTech pioneer EndoInnovate partnered with European distributor EuroMedi to expand distribution across the EU, leveraging a joint‑venture targeting market share growth. Meanwhile, BioStent Corp completed its acquisition of Helix Devices, adding a proprietary nitinol alloy platform that promises higher radial force and reduced migration. The FDA’s updated guidance on “non‑covered biliary stent labeling” released in Q2 2024 streamlines pre‑market submissions, encouraging smaller innovators to enter the field. Consumer trends show a shift toward outpatient ERCP procedures, driving demand for stents that combine ease of deployment with long‑term patency. Finally, VascuTech secured a $45 million Series C round to scale its 3‑D printed stent line, planning a new manufacturing hub in Singapore by 2025. Collectively, these moves underscore evolving Metal Non-Covered Biliary Stent industry trends toward minimally invasive, outpatient solutions.

EndoInnovate‑EuroMedi EU distribution pact accelerates adoption in Germany and France.

Helix Devices acquisition adds a high‑radial‑force nitinol design to BioStent’s portfolio.

FDA labeling update reduces time‑to‑market for new non‑covered stent submissions.

Analyst Overview

Overall, the Metal Non-Covered Biliary Stent market remains attractive due to sustained prevalence of malignant biliary obstruction and limited reimbursement constraints in mature economies. Competitive intensity is moderate; a handful of legacy manufacturers dominate, yet emerging Asian players are gaining share through cost‑advantage strategies. The long‑term outlook is positive, with CAGR projected above 6% through 2032 as aging demographics and expanding endoscopic programs drive volume. Innovation is focused on refined nitinol alloys, anti‑migration designs, and integrated delivery systems, but breakthrough breakthroughs are limited, keeping the product lifecycle relatively stable. Demand and supply are well‑balanced; manufacturers have scaled production capacities to meet incremental growth, though occasional raw‑material price spikes could pressure margins. Key risks include regulatory tightening on device safety, potential shifts toward fully covered or drug‑eluting alternatives, and geopolitical supply‑chain disruptions. Decision‑makers should monitor reimbursement policy trends and invest in differentiated engineering to preserve market positioning within the evolving Metal Non-Covered Biliary Stent market outlook.

12 items

1. Executive Summary

2. Metal Non-Covered Biliary Stent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Metal Non-Covered Biliary Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Metal Non-Covered Biliary Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Metal Non-Covered Biliary Stent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Metal Non-Covered Biliary Stent Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Metal Non-Covered Biliary Stent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Metal Non-Covered Biliary Stent Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Metal Non-Covered Biliary Stent Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Metal Non-Covered Biliary Stent Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Metal Non-Covered Biliary Stent Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Metal Non-Covered Biliary Stent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Metal Non-Covered Biliary Stent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Metal Non-Covered Biliary Stent Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Metal Non-Covered Biliary Stent Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Metal Non-Covered Biliary Stent Market Competition by Key Manufacturers

9.1. Global Metal Non-Covered Biliary Stent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Metal Non-Covered Biliary Stent: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Boston Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Taewoong Medical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Merit Medical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Cook Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. PNN Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Teleflex

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. C.R. Bard

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Metal Non-Covered Biliary Stent Market

Figure 4: Global Metal Non-Covered Biliary Stent Market: Drivers

Figure 5: Global Metal Non-Covered Biliary Stent Market: Challenges

Figure 6: Global Metal Non-Covered Biliary Stent Market: Trends

Figure 7: Global Metal Non-Covered Biliary Stent Market: Opportunity

Figure 8: Global Metal Non-Covered Biliary Stent Market: Restraint

Figure 9: Global Metal Non-Covered Biliary Stent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Metal Non-Covered Biliary Stent Market Value (USD Million) By Region

Figure 19: Global Metal Non-Covered Biliary Stent Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Metal Non-Covered Biliary Stent Market Value (USD Million) By Region

Figure 27: Global Metal Non-Covered Biliary Stent Market Share (%) By: Regions (2032)

Figure 28: Global Metal Non-Covered Biliary Stent Market Volume (K) By Region

Figure 29: Global Metal Non-Covered Biliary Stent Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Metal Non-Covered Biliary Stent Market Value (USD Million) By Region

Figure 37: Global Metal Non-Covered Biliary Stent Market Share (%) By: Regions (2032)

Figure 38: Global Metal Non-Covered Biliary Stent Market Volume (K) By Region

Figure 39: Global Metal Non-Covered Biliary Stent Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Metal Non-Covered Biliary Stent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Metal Non-Covered Biliary Stent Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Metal Non-Covered Biliary Stent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Metal Non-Covered Biliary Stent Market Value (USD Million) By Region

Table 14: Global Metal Non-Covered Biliary Stent Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Metal Non-Covered Biliary Stent Market Volume (K) By Region

Table 31: Global Metal Non-Covered Biliary Stent Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Metal Non-Covered Biliary Stent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Metal Non-Covered Biliary Stent Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Metal Non-Covered Biliary Stent Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Boston Scientific Basic Information And Sales Area

Table 52: Boston Scientific. Products Portfolio

Table 53: Taewoong Medical Basic Information And Sales Area

Table 54: Taewoong Medical. Products Portfolio

Table 55: Merit Medical Basic Information And Sales Area

Table 56: Merit Medical. Products Portfolio

Table 57: Cook Medical Basic Information And Sales Area

Table 58: Cook Medical. Products Portfolio

Table 59: PNN Medical Basic Information And Sales Area

Table 60: PNN Medical. Products Portfolio

Table 61: Teleflex Basic Information And Sales Area

Table 62: Teleflex. Products Portfolio

Table 63: C.R. Bard Basic Information And Sales Area

Table 64: C.R. Bard. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Metal Non-Covered Biliary Stent Market Value (USD Million) By Region

Table 74: Global Metal Non-Covered Biliary Stent Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Metal Non-Covered Biliary Stent Market Volume (K) By Region

Table 91: Global Metal Non-Covered Biliary Stent Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

FAQs

1. What is the current Metal Non-Covered Biliary Stent market size?

The Metal Non-Covered Biliary Stent market size was estimated at roughly USD 1.2 billion in 2023, reflecting strong demand across gastrointestinal oncology and benign biliary disease segments. This valuation incorporates sales of self‑expanding and balloon‑expandable stents worldwide.

2. What is the projected growth rate and forecast through 2032?

Analysts project a compound annual growth rate of 5.6 % for the Metal Non-Covered Biliary Stent market from 2024 to 2032, pushing total revenues to approximately USD 1.9 billion by the end of the forecast period. The future outlook is driven by expanding minimally invasive procedures.

3. Which key drivers are fueling market expansion?

Key drivers include rising incidence of malignant biliary obstruction, increasing adoption of endoscopic retrograde cholangiopancreatography (ERCP) for palliation, and growing preference for metal over plastic stents due to superior patency. Reimbursement improvements in North America and Europe further accelerate uptake.

4. What challenges could impede market growth?

Challenges comprise stent migration, tissue hyperplasia leading to restenosis, and limited data on long‑term outcomes for uncovered designs. Additionally, high upfront device cost and stringent regulatory pathways in emerging economies may restrict broader adoption significantly.

5. Which regions are leading in sales and why?

North America remains the dominant region, accounting for over 45 % of global revenue, thanks to advanced healthcare infrastructure and high ERCP procedure volumes. Europe follows closely, driven by strong reimbursement frameworks, while Asia‑Pacific shows rapid growth due to expanding hospital networks.

6. Who are the top companies competing in this market?

The Metal Non-Covered Biliary Stent market is led by Boston Scientific, Cook Medical, and Medtronic, each holding significant share through extensive product portfolios. Additional contenders such as Taewoong Medical, MicroTech and Terumo contribute niche innovations and regional strength.

7. What future opportunities are emerging for manufacturers?

Future opportunities include developing drug‑eluting uncovered stents to mitigate restenosis, integrating radiopaque markers for enhanced imaging, and targeting emerging markets with cost‑effective designs. The future outlook also envisions collaborations with AI‑driven navigation platforms to improve placement accuracy.

8. How is technology reshaping the Metal Non-Covered Biliary Stent market?

Advances in nitinol alloy engineering improve radial force while reducing profile, enabling delivery through smaller endoscopes. 3‑D printing allows patient‑specific geometry, and digital twin simulations support pre‑procedural planning. These technologies enhance clinical outcomes and drive competitive differentiation.

9. What is the regulatory landscape governing these stents globally?

Globally, Metal Non-Covered Biliary Stents are classified as Class II medical devices in the United States (FDA 510(k)) and as Class IIb in the EU under MDR. Emerging markets often require local clinical data, extending approval timelines and post‑market surveillance obligations.

Contact for Full Report

Loading report content...

Metal Non-Covered Biliary Stent Market Growing at CAGR — 2026 Report

Market Snapshot

Metal Non-Covered Biliary Stent Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Metal Non-Covered Biliary Stent Segmentation

Metal Non-Covered Biliary Stent Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Metal Non-Covered Biliary Stent market size?

2. What is the projected growth rate and forecast through 2032?

3. Which key drivers are fueling market expansion?

4. What challenges could impede market growth?

5. Which regions are leading in sales and why?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for manufacturers?

8. How is technology reshaping the Metal Non-Covered Biliary Stent market?

9. What is the regulatory landscape governing these stents globally?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Metal Non-Covered Biliary Stent Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Metal Non-Covered Biliary Stent Segmentation

Metal Non-Covered Biliary Stent Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Metal Non-Covered Biliary Stent market size?

2. What is the projected growth rate and forecast through 2032?

3. Which key drivers are fueling market expansion?

4. What challenges could impede market growth?

5. Which regions are leading in sales and why?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for manufacturers?

8. How is technology reshaping the Metal Non-Covered Biliary Stent market?

9. What is the regulatory landscape governing these stents globally?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation